Clinigen assisted a small UK-based pharmaceutical company in achieving Medicines and Healthcare products Regulatory Agency (MHRA) compliance by providing end-to-end support for a packaging redesign. This involved coordinating meetings with the MHRA, selecting an artwork provider, developing a new design, and managing regulatory submissions. The comprehensive approach ensured regulatory approval, cost savings, and enhanced product safety. Clinigen’s expertise and proactive communication were key to the project’s success.

Read the case study to learn how Clinigen’s end-to-end support in assuring MHRA compliance resulted in improved product safety and significant cost savings.